Skip to main content
Vericel Corporation (VCEL)
NASDAQ: VCEL · Real-Time Price · USD
35.65
-1.27 (-3.44%)
At close: Apr 28, 2026, 4:00 PM EDT
36.01
+0.36 (1.01%)
After-hours: Apr 28, 2026, 4:52 PM EDT

Vericel Revenue

In the year 2025, Vericel had annual revenue of $276.26M with 16.45% growth. Vericel had revenue of $92.92M in the quarter ending December 31, 2025, with 23.27% growth.

Revenue (ttm)
$276.26M
Revenue Growth
+16.45%
P/S Ratio
6.56
Revenue / Employee
$694,118
Employees
398
Market Cap
1.82B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025276.26M39.04M16.45%
Dec 31, 2024237.22M39.71M20.10%
Dec 31, 2023197.52M33.15M20.17%
Dec 31, 2022164.37M8.18M5.24%
Dec 31, 2021156.18M32.01M25.77%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Galapagos NV 1.31B
Harmony Biosciences Holdings 868.45M
AnaptysBio 234.60M
Stoke Therapeutics 184.42M
Syndax Pharmaceuticals 172.35M
Recursion Pharmaceuticals 74.68M
Mesoblast 65.38M
Taysha Gene Therapies 9.77M
Revenue Rankings

VCEL News

More News